The 7th Annual Conference is Coming Back Next Year. More Information Coming Soon.

June 26-27, 2018 | Chicago, IL

BROCHURE MAILING LIST SPEAKER OPPS SPONSOR OPPS

2017 Featured Speakers

 

Ron Alfa, MD, Ph.D., Vice President, Discovery and Product, Recursion Pharmaceuticals

Bobbie Ann Austin, Ph.D., Program Officer, Drug Development Partnership Programs, NCATS, Office of the Director, National Institutes of Health

Xavier Paoli, CCO and VP of R&D Operations, PharNext SA

Vidula Sukhatme, Founder & CEO, Global Cures

2017 Sponsors

  

 

Join us at the 7th Annual Drug Repositioning, Repurposing and Rescue Conference in Chicago, where attendees will meet and learn from the world’s foremost experts in the fields of repositioning and repurposing.


Why Attend

As the Single Longest-Running Conference in the Space, Arrowhead Publishers’ annual event continues to be the “go to” meeting for pharma executives, academicians, researchers and patient advocacy groups who want to keep abreast of new developments in the field, learn from experts and meet possible collaborators and partners. Our agenda incorporates Case Studies, Genetics/Genomics, new Cutting-Edge Technology (including artificial intelligence), Regulatory Guidance, Big Data Approaches, New Drug Discovery Paradigms, Partnering Models, Crowdsourcing Methods and repurposing projects for Rare/Orphan Diseases, Tropical DiseasesCancer and many other diseases and conditions.


About the Field of Repositioning

Drug repositioning has emerged as a cost-effective and quicker alternative to traditional drug discovery and development. Both approved drugs and those that have proven safe in Phase I/II trials save vast amounts of clinical development time and money. By mining existing drugs for new uses, researchers can focus instead on latter stage clinical trials.

Co-Located With:

GLOBAL HEALTH REPURPOSING AWARDS 2018
Join us for the Global Health Repurposing Awards, gathering leaders in the BioScience, philanthropic and scientific communities to celebrate patient impact created through repurposing research, while raising funds for Cures Within Reach, a non-profit dedicated to improving patient lives through repurposing.

For more information about this event, CLICK HERE.

JUNE 26, 2018 Time TBA

 

Download Brochure

Speaking Opportunities

Sponsor/Exhibit Opportunities

Join Conference Mailing List

Testimonials

 

"They were great presentations, which delivered valuable information ranging from the computational method to rational selections, successful drug repositioning cases, patent knowledge, and foundation grant opportunities."

“It was a perfectly organized conference. The topics were very good combined and there was enough time for discussion and networking. It was also a perfect size.”

“Great group of people was assembled making for excellent discussion and networking”

"I was able to have an opportunity to interact with all attendees."

“I liked that everyone here is openly networking and trying to help each other succeed. Thank you for selecting great speakers.”

"Quality of attendees was great!"

"Very well put together topics - diverse and quite interesting."

"Hearing multiple perspectives and approaches to drug repurposing was very helpful and gave a broad picture of what is happening."

"The quality of presentations and the combinations of different approaches were excellent."

"I appreciated the diversity of preclinical and clinical, industry and academics, for-profit and non-profit."

More About Drug Repositioning, Repurposing and Rescue

Drug repositioning has emerged as a potentially cost-effective and quicker alternative to provide new drugs for pharmaceutical companies’ waning pipelines. Approved drugs have already met with the FDA’s approval therefore, the early stages of drug development can be bypassed. By mining existing drugs for new uses, researchers can focus instead on the clinical testing portion of the process. This shortens the development timeline and gets new treatments to patients faster. With new technologies and approaches, drug repositioning has become more streamlined and less accidental than it was in the past. By using a more systematic approach, existing compounds are being tested for both common and neglected diseases faster and with more success.

Who Should Attend

 Organizations

► Pharmaceutical Companies ► Contract Research Organizations
► Specialist Repositioning Companies ► Government/Regulatory Bodies
► Mid Cap/SME Biotechs ► Academic/Research Institutes
► NGOs/Public Health ► Patient Advocacy Organizations 

VPs, Directors, Managers & Associates in the Following Areas:

► Research & Development ► Indication Expansion ► Toxicology
► Business Development ► Portfolio Management ► Product Development
► Drug Discovery ► Commercialization ► Chemistry
► Medical Affairs ► Drug Repositioning  ► Informatics
► Scientific Affairs ► Drug Repurposing  ► Translational Biology
► Clinical Development ► Asset Management

Contact Us

Arrowhead Publishers
5780 Lincoln Drive, Suite 205
Edina, MN 55436
866-945-0263
enquiries@arrowheadpublishers.com

 

About Us

Our events give attendees a conference experience that encompasses learning, networking and professional growth. We strive to facilitate connections. At our events, attendees, speakers, sponsors and exhibitors have opportunities to network and then to utilize those connections to further their professional goals. At Arrowhead Publishers, our focus is on bringing life sciences industry professionals together to help move research forward.

READ MORE